ArticleFrontiers in oncology2021

A Nomogram to Predict Disease-Free Survival Following Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.

Meizhen Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.